ALISON LAFLOWER: Open Payments
NPI 1114157633 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,881 in 157 payments from 43 companies in 2025. Trend: 2023 $2,418 · 2024 $2,799 · 2025 $4,881
Food & beverage: $4,598Education: $283
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $419 |
| AstraZeneca Pharmaceuticals LP | 8 | $345 |
| E.R. Squibb & Sons, L.L.C. | 7 | $331 |
| Merck Sharp & Dohme LLC | 10 | $297 |
| PFIZER INC. | 7 | $294 |
| Novocure Inc. | 3 | $264 |
| Eisai Inc. | 7 | $242 |
| BeOne Medicines USA, Inc. | 3 | $220 |
| Incyte Corporation | 4 | $207 |
| Adaptive Biotechnologies Corporation | 4 | $176 |
Products named: KEYTRUDA, Optune Lua (NovoTTF-200T), Lenvima, KISQALI, OPDIVO, IMFINZI, clonoSEQ, Nubeqa.
Industry payments across IN — which companies pay providers there.
